Brief: Renovorx Announces Pricing Of Initial Public Offering
26/08/2021 02:38
RenovoRx Inc RNXT.O :
* RENOVORX ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING
* PRICING OF ITS UNDERWRITTEN INITIAL PUBLIC OFFERING OF
1,850,000
UNITS AT A PUBLIC OFFERING PRICE PER UNIT OF $9.00
Source text for Eikon: ID:nPn65M8tVa
Further company coverage: RNXT.O
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer